References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:1–10.
- Nagpal JK, Das BR. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol. 2003;39(3):213–221. doi:https://doi.org/10.1016/S1368-8375(02)00162-8.
- González-Mariscal L, Lechuga S, Garay E. Role of tight junctions in cell proliferation and cancer. Prog Histochem Cytochem. 2007;42:1–57.
- Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochimica Et Biophysica Acta (Bba)-biomembranes. 2008;1778(3):660–669. doi:https://doi.org/10.1016/j.bbamem.2007.07.012.
- Jankowski JA, Bruton R, Shepherd N, Sanders DS. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Molecular Pathology. 1997;50(6):289. doi:https://doi.org/10.1136/mp.50.6.289.
- van Dijk M, Göransson SA, Strömblad S. Cell to extracellular matrix interactions and their reciprocal nature in cancer. Exp Cell Res. 2013;319(11):1663–1670. doi:https://doi.org/10.1016/j.yexcr.2013.02.006.
- Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, Farah CS. Epithelial to mesenchymal transition (EMT) biomarkers–E-cadherin, beta-catenin, APC and Vimentin–in oral squamous cell carcinogenesis and transformation. Oral Oncol. 2012;48(10):997–1006. doi:https://doi.org/10.1016/j.oraloncology.2012.05.011.
- Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol. 2009;45(8):647–653. doi:https://doi.org/10.1016/j.oraloncology.2009.02.006.
- Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer. Cancer and Metastasis Reviews. 2009;28(1–2):151–166. doi:https://doi.org/10.1007/s10555-008-9179-y.
- Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochimica Et Biophysica Acta (Bba)-biomembranes. 2009;1788(4):872–891. doi:https://doi.org/10.1016/j.bbamem.2008.11.005.
- Bazzoni G, Martı́nez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. Journal of Biological Chemistry. 2000;275(27):20520–20526. doi:https://doi.org/10.1074/jbc.M905251199.
- Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986;103(3):755–766. doi:https://doi.org/10.1083/jcb.103.3.755.
- Munshi HG, Ghosh S, Mukhopadhyay S, Wu YI, Sen R, Green KJ, Stack MS. Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes. Journal of Biological Chemistry. 2002;277(41):38159–38167. doi:https://doi.org/10.1074/jbc.M202384200.
- Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995;7(5):619–627. doi:https://doi.org/10.1016/0955-0674(95)80102-2.
- Downer CS, Speight PM. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur J Cancer B Oral Oncol. 1993;29(4):303–305. doi:https://doi.org/10.1016/0964-1955(93)90053-H.
- Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251(5000):1451–1455. doi:https://doi.org/10.1126/science.2006419.
- Nagafuchi A. Molecular architecture of adherens junctions. Curr Opin Cell Biol. 2001;13(5):600–603. doi:https://doi.org/10.1016/S0955-0674(00)00257-X.
- Scanlon CS, Van Tubergen EA, Inglehart RC, D’Silva NJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res. 2013;92(2):114–121. doi:https://doi.org/10.1177/0022034512467352.
- Greene FL, Balch CM, Fleming ID, Fritz A, Haller DG, Morrow M, Page DL, editors. AJCC cancer staging handbook: TNM classification of malignant tumors. Springer Science & Business Media; 2002.
- Ramadas K, Lucas E, Thomas G, et al. A digital manual for the early diagnosis of oral neoplasia. Lyon, France: international Agency for Research on Cancer. 2008. https://screening.iarc.fr/atlasoral.php
- SEER Cancer Stat Facts: Oral cavity and pharynx cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/oralcav.html
- Upadhaya P, Barhoi D, Giri A, Bhattacharjee A, Giri S. Joint detection of claudin‐1 and junctional adhesion molecule‐A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma. J Cell Biochem. 2019;120(10):18117–18127. doi:https://doi.org/10.1002/jcb.29115.
- Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2008;27(55):6930–6938. doi:https://doi.org/10.1038/onc.2008.344.
- Meerschaert K, Tun MP, Remue E, De Ganck A, Boucherie C, Vanloo B, Degeest G, Vandekerckhove J, Zimmermann P, Bhardwaj N, et al. The PDZ2 domain of zonula occludens-1 and-2 is a phosphoinositide binding domain. Cellular and Molecular Life Sciences. 2009;66(24):3951–3966. doi:https://doi.org/10.1007/s00018-009-0156-6.
- Yu D, Marchiando AM, Weber CR, et al. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proceedings of the National Academy of Sciences. 2010;107:8237–8241.
- Qiu X, Wu Z, Wang X, et al. Expression of ZO-1 in laryngeal squamous cell carcinoma and its prognostic value. Int J Clin Exp Pathol. 2016;9:11615–11622.
- National Institute of Dental and Craniofacial Research. Oral cancer incidence (new cases) by age, race, and gender. https://www.nidcr.nih.gov/research/data-statistics/oral-cancer/incidence [accessed February 2021]
- Yuwanati MB, Tupkari JV, Avadhani A. Expression of E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: an in vivo study. Journal of Clinical & Experimental Investigations/Klinik Ve Deneysel Arastirmalar Dergisi. 2011;2:4.
- Rosso M, Majem B, Devis L, Lapyckyj L, Besso MJ, Llauradó M, Abascal MF, Matos ML, Lanau L, Castellví J, et al. E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness. PloS One. 2017;12(9):e0184439. doi:https://doi.org/10.1371/journal.pone.0184439.
- Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W. E-cadherin and β-catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol. 2005;3(1):1. doi:https://doi.org/10.1186/1477-7819-3-38.
- Christou N, Perraud A, Blondy S, Jauberteau M-O, Battu S, Mathonnet M. E-cadherin: a potential biomarker of colorectal cancer prognosis. Oncol Lett. 2017;13(6):4571–4576. doi:https://doi.org/10.3892/ol.2017.6063.
- Sridevi U, Jain A, Velpula Nagalaxmi UV, Kumar UV, Goyal S. Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. Eur J Dent. 2015;9(3):364. doi:https://doi.org/10.4103/1305-7456.163238.
- Kaur G, Carnelio S, Rao N, Kaur G. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study. Indian Journal of Dental Research. 2009;20(1):71. doi:https://doi.org/10.4103/0970-9290.49075.
- Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous β-catenin. Clinical Cancer Research. 2004;10(16):5455–5463. doi:https://doi.org/10.1158/1078-0432.CCR-04-0372.
- Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999;24(2):73–76. doi:https://doi.org/10.1016/S0968-0004(98)01343-7.
- de Vicente JC, Fernandez-Valle A, Vivanco-Allende B, et al. The prognostic role of claudins-1 and-4 in oral squamous cell carcinoma. Anticancer Res. 2015;35:2949–2959.
- Dos Reis PP, Bharadwaj RR, Machado J, MacMillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P, Irish J, Kamel-Reid S, et al. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2008;113(11):3169–3180. doi:https://doi.org/10.1002/cncr.23934.
- de Aquino AR, de Carvalho CH, Nonaka CF, Freitas RDA, de Souza LB, Pinto LP. Immunoexpression of claudin-1 and Nm23-H1 in metastatic and nonmetastatic lower lip squamous-cell carcinoma. Applied Immunohistochemistry & Molecular Morphology. 2012;20(6):595–601. doi:https://doi.org/10.1097/PAI.0b013e3182505c22.
- Dhawan P, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115(7):1765–1776. doi:https://doi.org/10.1172/JCI24543.
- Xu J, Kausalya PJ, Phua DC, Ali SM, Hossain Z, Hunziker W. Early embryonic lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development. Mol Cell Biol. 2008;28(5):1669. doi:https://doi.org/10.1128/MCB.00891-07.